ICER’s Latest: A draft evidence report on new treatment for Beta Thalassemia

On April 13, 2022, ICER released its draft evidence report, “Betibeglogene Autotemcel for Beta Thalassemia.” This is the first step in ICER’s review process; ICER is scheduled to release a final...

Businesses With High-Value, Low-Cost Health Insurance Receive First-Ever Health Plan Hero Awards

Six small businesses from across the country were among the first companies ever to receive a national award for their innovative, outstanding employer-sponsored health program. The companies...

More of the Same: ICER’s latest salvo on rare diseases

Earlier this month, ICER released a white paper titled “The Next Generation of Rare Disease Drug Policy: Ensuring Both Innovation and Affordability.” If you have been monitoring ICER’s work over the...

 Making effective decisions in health care requires a thorough understanding of the patient perspective, as well as robust, precise measures of response to therapy. The Patient Access & Affordability Project evaluates the various frameworks used to assess and demonstrate the value of new treatments to ensure that the patient is kept at the center of health care decisions.

The Latest Insights

More of the Same: ICER’s latest salvo on rare diseases

More of the Same: ICER’s latest salvo on rare diseases

Earlier this month, ICER released a white paper titled “The Next Generation of Rare Disease Drug Policy: Ensuring Both Innovation and Affordability.” If you have been monitoring ICER’s work over the years, the paper likely matches your expectations. Ostensibly, the...

read more
Event: Health Plan Heroes Awards Program and Roundtable

Event: Health Plan Heroes Awards Program and Roundtable

Patients Rising's first annual Health Plan Heroes event will honor companies that have adopted innovative benefit design for their employees. In addition, a panel of experts will have a roundtable discussion on ways for employers to enhance patient access to care as...

read more

Get Updates in Your Inbox

Sign Up.  Stay Informed.